Keryx Biopharma (KERX) Misses Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts KERX Hot Sheet
Price: $3.36 --0%
Financial Fact:
Basic and diluted net loss per common share: -0.39
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Basic and diluted net loss per common share: -0.39
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Keryx Biopharma (NASDAQ: KERX) reported Q3 EPS of ($0.20), $0.02 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $15 million versus the consensus estimate of $18.04 million.
For earnings history and earnings-related data on Keryx Biopharma (KERX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- TJX Cos. (TJX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance
- Deere & Co. (DE) Tops Q3 EPS by 41c, raises guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
